darolutamide 300 MG Oral Tablet [Nubeqa]
- RxCUI
- 2180336
- RxNorm name
- darolutamide 300 MG Oral Tablet [Nubeqa]
- Display name
- darolutamide 300 MG Oral Tablet [Nubeqa]
- Full name
- darolutamide 300 MG Oral Tablet [Nubeqa]
- Term type
- SBD
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:49
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NUBEQA | DAROLUTAMIDE | Bayer HealthCare Pharmaceuticals Inc. | 1a7cb212-56e4-4b9d-a73d-bfee7fe4735e | 2025-06-03 | Warnings, Adverse reactions | 2180336 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1a7cb212-56e4-4b9d-a73d-bfee7fe4735e | darolutamide 300 MG Oral Tablet [Nubeqa] | SBD | 23 | These highlights do not include all the information needed to use NUBEQA safely and effectively. See full prescribing information for NUBEQA. NUBEQA ® (darolutamide) tablets, for oral use Initial U.S. Approval: 2019 | 20250603 |
| 1a7cb212-56e4-4b9d-a73d-bfee7fe4735e | NUBEQA 300 MG Oral Tablet | PSN | 23 | These highlights do not include all the information needed to use NUBEQA safely and effectively. See full prescribing information for NUBEQA. NUBEQA ® (darolutamide) tablets, for oral use Initial U.S. Approval: 2019 | 20250603 |
| 1a7cb212-56e4-4b9d-a73d-bfee7fe4735e | Nubeqa 300 MG Oral Tablet | SY | 23 | These highlights do not include all the information needed to use NUBEQA safely and effectively. See full prescribing information for NUBEQA. NUBEQA ® (darolutamide) tablets, for oral use Initial U.S. Approval: 2019 | 20250603 |